Pipeline
BIONOXX strives to provide patients with new treatment by focusing on research
and development of immunoe-oncology drugs; oncolytic viruses and cell therapies.
and development of immunoe-oncology drugs; oncolytic viruses and cell therapies.
Discovery
Preclinical
IND
Phase I
Phase II
Indication
OV (Oncolytic virus)
mOTS-412
mOTS-412 + anti PD-L1
mOTS-412 + anti PD-L1
mWOTS-418
Solid tumor
Undisclosed
OV + CAR-T
UTTA CAR-T
Undisclosed
Immune Equalizer™
BNX-E4
SJIA
